Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 19401-19450 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT06496282
Lemborexant on Improving Sleep Quality Among Hospital Rotating Shift Workers
PHASE3Recruiting
50 participants
Started: Aug 31, 2024 · Completed: Jul 31, 2026
1 condition2 sponsors1 location
NCT06540716
Inspire Singapore Study
NARecruiting
44 participants
Started: Aug 31, 2024 · Completed: Dec 31, 2025
3 conditions1 sponsor2 locations
NCT06932471
Study of Safety and Efficacy of MY008211A in Patients With Residual Anemia Despite Anti-C5 Antibody Treatment
PHASE3Recruiting
20 participants
Started: Aug 30, 2024 · Completed: Dec 30, 2025
1 condition1 sponsor1 location
NCT06582771
A Study of Sotorasib in People with Non-Small Cell Lung Cancer
PHASE2Recruiting
39 participants
Started: Aug 30, 2024 · Completed: Aug 31, 2026
1 condition1 sponsor7 locations
NCT06425302
A Study to Evaluate the Efficacy and Safety of Golcadomide in Combination With Rituximab in Participants With Newly Diagnosed Advanced Stage Follicular Lymphoma
PHASE2Recruiting
90 participants
Started: Aug 30, 2024 · Completed: Nov 27, 2028
1 condition1 sponsor68 locations
NCT06438822
Cadonilimab Combined With Liposomal Irinotecan Plus Leucovorin and Fluorouracil for Advanced Cholangiocarcinoma
PHASE2Recruiting
51 participants
Started: Aug 30, 2024 · Completed: Nov 30, 2026
1 condition1 sponsor1 location
NCT06677775
Pathological Positivity Rate in Prostate Cancer Patients with PI-RADS 4 and First Negative Biopsy
N/ARecruiting
30 participants
Started: Aug 30, 2024 · Completed: Aug 30, 2025
1 condition1 sponsor1 location
NCT06932744
Study of Safety and Efficacy of MY008211A in Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients Who Are Naive to Complement Inhibitor Therapy
PHASE3Recruiting
66 participants
Started: Aug 30, 2024 · Completed: Dec 30, 2025
1 condition1 sponsor2 locations
NCT06708481
Resin Infiltration Vs Self-Assembling Peptide (P11-4) in Treating White Spot Lesions
EARLY_PHASE1Recruiting
150 participants
Started: Aug 30, 2024 · Completed: Feb 28, 2025
1 condition3 sponsors1 location
NCT06791434
Assessing the Benefits of Dry Needling for Low Back Pain When Combined with Regular Treatment
PHASE4Recruiting
140 participants
Started: Aug 30, 2024 · Completed: Aug 31, 2025
1 condition1 sponsor1 location
NCT06535230
Anesthesia Induction with the Target-controlled Infusion of Propofol in High-risk Patients
NARecruiting
200 participants
Started: Aug 30, 2024 · Completed: Jun 30, 2025
2 conditions1 sponsor1 location
NCT06515574
Effect of Developmental Care on Very Low Birth Weight Infants
NARecruiting
1,600 participants
Started: Aug 30, 2024 · Completed: Dec 1, 2027
1 condition1 sponsor2 locations
NCT06599957
Innovative Drug Delivery Nanophotonic Platform for Implementation of Sarcoma Therapy
N/ARecruiting
30 participants
Started: Aug 30, 2024 · Completed: Aug 30, 2026
1 condition3 sponsors2 locations
NCT06503731
A Study to Evaluate the Safety and Tolerability of Efgartigimod PH20 SC Given by Prefilled Syringe in Kidney Transplant Recipients With Antibody-Mediated Rejection (AMR)
PHASE2Recruiting
30 participants
Started: Aug 30, 2024 · Completed: Sep 30, 2027
1 condition1 sponsor20 locations
NCT06492122
Study With [225Ac]Ac-FL-020 in mCRPC Participants
PHASE1Recruiting
35 participants
Started: Aug 30, 2024 · Completed: Dec 31, 2026
1 condition1 sponsor6 locations
NCT06509009
Nimotuzumab Combined With TGP as First-line Therapy in Patients With Recurrent/Metastatic Nasopharyngeal Carcinoma
PHASE2Recruiting
30 participants
Started: Aug 30, 2024 · Completed: May 30, 2027
1 condition1 sponsor1 location
NCT06529419
A Dose Range-Finding Study to Assess the Efficacy and Safety of Multiple Dose Levels of AZD8630 in Adults With Uncontrolled Asthma at Risk of Exacerbations
PHASE2Recruiting
516 participants
Started: Aug 30, 2024 · Completed: Apr 6, 2026
1 condition1 sponsor234 locations
NCT06593678
Telerehabilitation in Cancer Patients: Optimization of Prehabilitation and Rehabilitation Following Colorectal Resection
NARecruiting
54 participants
Started: Aug 30, 2024 · Completed: Jul 31, 2026
3 conditions4 sponsors1 location
NCT06625138
Trial of Latex Vs Non-latex Hemorrhoid Banding
NARecruiting
164 participants
Started: Aug 30, 2024 · Completed: Oct 1, 2026
2 conditions1 sponsor1 location
NCT05911828
A Study to Determine Safety, Tolerability, and Pharmacokinetics of Different Orally Administered Regimens of the Combination ZY19489-Ferroquine in Adult Asymptomatic Plasmodium Falciparum Carriers
PHASE1Recruiting
36 participants
Started: Aug 30, 2024 · Completed: May 30, 2025
3 conditions1 sponsor1 location
NCT06509750
The Postprandial Effects of a Carob-containing Meal
NARecruiting
20 participants
Started: Aug 30, 2024 · Completed: May 31, 2025
1 condition1 sponsor1 location
NCT06254924
Qoyangnuptu: Qoyangnuptu Intervention (QI) App
NARecruiting
24 participants
Started: Aug 30, 2024 · Completed: Oct 1, 2026
1 condition1 sponsor1 location
NCT06423040
Social Media Chatbot on Physical Activity Education for Older Adults
NARecruiting
104 participants
Started: Aug 30, 2024 · Completed: Jul 31, 2025
4 conditions1 sponsor1 location
NCT06564142
Evaluation of Efficacy of Povetacicept in Adults With Immunoglobulin A Nephropathy (IgAN)
PHASE3Recruiting
480 participants
Started: Aug 30, 2024 · Completed: Sep 30, 2028
1 condition1 sponsor318 locations
NCT06607887
The Role of Postoperative Antibiotics in Laparoscopic Cholecystectomy
PHASE4Recruiting
300 participants
Started: Aug 30, 2024 · Completed: Dec 30, 2024
2 conditions1 sponsor1 location
NCT07190950
Effects of Low-level Laser Therapy on Soft and Hard Tissue Healing After Impacted Mandibular Third Molar Extraction
NARecruiting
22 participants
Started: Aug 30, 2024 · Completed: Dec 31, 2025
3 conditions1 sponsor1 location
NCT06337474
An Clinical Study of CD19 CAR NK Cells for the Treatment of Refractory Primary Immune Thrombocytopenia
EARLY_PHASE1Recruiting
9 participants
Started: Aug 30, 2024 · Completed: Jul 30, 2026
1 condition2 sponsors1 location
NCT06541834
Predicting the Risk of Diabetic Neurodegenerative Disorders by Artificial Intelligence Tools Based on Retinal Imaging
N/ARecruiting
250 participants
Started: Aug 30, 2024 · Completed: Aug 30, 2026
2 conditions3 sponsors1 location
NCT06764511
Evaluation of Response to Biosimilar Erythropoietin Alfa Therapy in Anemic Patients With Myelodysplastic Syndrome
N/ARecruiting
60 participants
Started: Aug 30, 2024 · Completed: Apr 30, 2025
1 condition1 sponsor1 location
NCT06723522
High Definition Transcranial Direct Current Stimulation of Right Inferior Frontal Gyrus to Improve Social Impairments in Children with Autism
NARecruiting
60 participants
Started: Aug 30, 2024 · Completed: Jul 31, 2026
1 condition1 sponsor1 location
NCT06610201
A Study of Bleeding and Treatment in Participants With Von Willebrand Disease
N/ARecruiting
200 participants
Started: Aug 30, 2024 · Completed: Jun 30, 2026
7 conditions1 sponsor15 locations
NCT05723471
Impact of a Collaborative Program of Physical Activity of Newly-diagnosed Cancer Patients
NARecruiting
350 participants
Started: Aug 30, 2024 · Completed: Dec 31, 2028
1 condition1 sponsor2 locations
NCT06561451
Live Birth Rate Between ICSI and AOA and ICSI Alone in Patients With Severe Teratospermia
NARecruiting
208 participants
Started: Aug 30, 2024 · Completed: Dec 30, 2026
2 conditions1 sponsor1 location
NCT06503263
Zanubrutinib and Lenalidomide as Maintenance Therapy in DLBCL
PHASE2Recruiting
240 participants
Started: Aug 30, 2024 · Completed: Dec 30, 2030
1 condition1 sponsor1 location
NCT06944366
Comparing Exposure v Imagery Rescripting in People With OCD: a SCED
NARecruiting
10 participants
Started: Aug 30, 2024 · Completed: May 20, 2025
1 condition1 sponsor1 location
NCT06554366
Bacterial Load Reduction by GentleWave and EdgePro Irrigation Systems in Mandibular Necrotic Molars
NARecruiting
30 participants
Started: Aug 30, 2024 · Completed: Apr 30, 2026
1 condition1 sponsor1 location
NCT06313710
Head Down Position for Successful Recanalization of Anterior Circulation Large Vessel Occlusion (HOPES4)
NARecruiting
90 participants
Started: Aug 30, 2024 · Completed: Nov 1, 2025
1 condition1 sponsor1 location
NCT06722638
Virtual Reality During Lumbar Punctures in Acute Lymphoblastic Leukemia
NARecruiting
40 participants
Started: Aug 30, 2024 · Completed: Dec 31, 2026
1 condition2 sponsors1 location
NCT06184516
Assessment of Decision Tool to Select Women for Gynecologic Sparing Radical Cystectomy
PHASE2Recruiting
147 participants
Started: Aug 30, 2024 · Completed: Mar 31, 2028
1 condition1 sponsor1 location
NCT06540066
A Study of BGB-B3227 Alone and in Combination With Tislelizumab in Participants With Advanced or Metastatic Solid Tumors
PHASE1Recruiting
75 participants
Started: Aug 30, 2024 · Completed: Jan 31, 2027
4 conditions1 sponsor12 locations
NCT06663644
Muscle Energy Technique in Patients With Nonspecific Low Back Pain
NARecruiting
28 participants
Started: Aug 30, 2024 · Completed: Dec 15, 2024
1 condition1 sponsor1 location
NCT05924672
Efficacy of Ra-223 in PSMA PET Optimally Selected Patients
PHASE2Recruiting
54 participants
Started: Aug 30, 2024 · Completed: May 31, 2028
3 conditions2 sponsors1 location
NCT06520358
Acute Intermittent Hypoxia to Improve Airway Protection in Chronic Traumatic Brain Injury
NARecruiting
5 participants
Started: Aug 30, 2024 · Completed: Jul 30, 2026
1 condition1 sponsor1 location
NCT06096142
The Solaris DE Endoprosthesis for the Treatment of AV Access Stenosis or Occlusion
NARecruiting
120 participants
Started: Aug 30, 2024 · Completed: Feb 29, 2028
3 conditions1 sponsor6 locations
NCT06608888
Unveiling the Neural Mechanisms of 5-HT7 in Sleep Apnea Induced by Arousal Dysregulation
N/ARecruiting
140 participants
Started: Aug 30, 2024 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT06602973
Relationships Between Exercise and Appetite in Women With Loss of Control Eating
NARecruiting
26 participants
Started: Aug 30, 2024 · Completed: Aug 31, 2026
3 conditions1 sponsor1 location
NCT06533345
VCOM Pain Free Research
NARecruiting
120 participants
Started: Aug 30, 2024 · Completed: Aug 1, 2027
1 condition1 sponsor1 location
NCT06561867
Ticagrelor Versus Cilostazol in Ischemic Stroke
PHASE3Recruiting
900 participants
Started: Aug 30, 2024 · Completed: Dec 20, 2025
1 condition1 sponsor1 location
NCT06838338
JAB-21822 Combined With Chemotherapy in Second-line KRAS G12C CRC
PHASE2Recruiting
30 participants
Started: Aug 29, 2024 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT05854524
Exercise Neuroprotection in Parkinson's Disease
NARecruiting
90 participants
Started: Aug 29, 2024 · Completed: Dec 30, 2026
1 condition1 sponsor1 location